New data will be presented about Precise® Molecular Residual Disease (MRD) Test and MyRisk® Hereditary Cancer Test ...
StockStory.org on MSN
Why Myriad Genetics (MYGN) stock is up today
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 2.5% in the afternoon session after the ...
New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in ...
Wistar Institute scientist Maureen Murphy wants to solve a decades-long mystery: Why is ovarian cancer often resistant to ...
A 46-year-old man with advanced lung cancer recovered after doctors used Next Generation Sequencing to identify a rare ALK ...
In a recent interview with CURE, Dr. Kai Tsao broke down current treatment advancements for patients with prostate cancer.
Gastric Cancer Diagnostics Market size was valued at US$ 3.5 Bn in 2024 and is projected to reach US$ 6.9 Bn by 2035, growing ...
UCLA researchers have developed a CAR-NKT cell therapy that has been more effective than current immunotherapies at fighting ...
In the field of cancer research, bioinformatics plays a pivotal role in dissecting the intricate molecular interactions that dictate cancer development and ...
A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果